Table 3.

Characteristics of IBD patient cohort for stool ND6 analysis.

	Active (n = 45)	Remission (n = 9)	Non-IBD (n = 5)
UC	24	3
CD	18	5
IBD-U	3	1
Age (years)	37.6 (2.0)	42.6 (5.3)	48.0 (3.9)
Female/male	23/22	3/6	3/2
C-reactive protein (mg/dL)	31.7 (8.7)	3.6 (0.9)	NA
Stool calprotectin (μg/g)	1255.0 (147.4)	227.9 (97.2)	115.4 (44.7)
No. of in-patients for active IBD treatment (%)	35 (77%)

Abbreviations: CD, Crohn’s disease; FPR1, formylated peptide receptor-1; IBD, inflammatory bowel disease; UC, ulcerative colitis.

Continuous data are presented as mean ± standard error of the mean (SEM).